Biotech

Scientists have developed a novel brain-computer interface (BCI) capable of simultaneously decoding a paralyzed individual's attempts to speak and gesture, translating these impulses into text and the movements of a digital avatar.

Researchers have developed a novel method using human lung organoids to model tissue-resident antiviral T cell responses, as detailed in a study published online on October 7, 2026, in the journal Nature.

Human brain organoids have been successfully grafted into mice that lack a cortex, a significant advancement published online on October 6, 2026, in Nature. This groundbreaking research, detailed in the publication doi:10.1038/d41586-026-02967-7, allows for the creation of cell-based models…

Nature published a retraction note on October 1, 2026, concerning the research article titled "Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway." The retraction note, identified by the digital object identifier (DOI) 10.1038/s41586-026-11149-4, indicates…

Novartis AG has entered into a substantial licensing agreement with Abogen Biosciences, a Chinese biotechnology company, to acquire rights for an mRNA-based autoimmune therapy. This deal, announced on March 18, 2024, could potentially reach a total value of up…

Researchers developing lab-grown brain organoids are correctly prioritizing biosafety, ethical considerations, and the inclusion of patient groups and the public in their work, according to an editorial published online in Nature on September 29, 2026.

Origin Genomics, a startup company, is actively pursuing the objective of demonstrating that the potential advantages of its gene-editing technology for human embryos surpass the associated risks. The company's focus is on editing genes that are known to cause diseases…

Anthropic's artificial intelligence research division has identified novel DNA editing systems within viruses that exhibit capabilities analogous to CRISPR-Cas9 technology. This discovery was made through an extensive computational analysis involving approximately 950 AI agents, which collectively dedicated over 21 hours…

A recent publication in the esteemed scientific journal Nature, dated September 28, 2026, introduces a new generation of genome editing technologies poised to significantly expand the scope of genetic manipulation.

A pioneering CRISPR-based therapy has demonstrated a remarkable ability to reduce "bad" cholesterol levels by approximately half in patients suffering from challenging lipid disorders, with these significant reductions persisting for a full year following a single administration.

Researchers have employed CRISPR gene editing technology to modify donor stem cells, creating a potential new strategy for treating aggressive blood cancers. This innovative approach focuses on removing the CD33 protein from these stem cells.

New research on heart transplants in mice indicates that young donor organs may not confer lasting rejuvenation, as they appear to adopt the biological age of the recipient. This finding, published in a study involving heart transplants in mice, casts…

Anthropic announced on May 15, 2024, that its artificial intelligence model, Claude, has discovered a novel enzyme system with capabilities similar to CRISPR gene-editing technology. This scientific breakthrough was revealed by the AI safety and research company amid a period…

Researchers have identified the protein Lsp2 as a critical link between the mTORC1 signaling pathway and the translation of TOP (Terminal Oligopyrimidine) mRNAs, a process that directly impacts lifespan in the fruit fly Drosophila melanogaster.

Anthropic announced that its artificial intelligence model, Claude, has autonomously discovered a new enzyme system. The company is comparing this discovery to the revolutionary gene-editing tool CRISPR, highlighting its potential significance in biological research and applications.

Scientists have engineered a revolutionary needle-thin brain implant, a single flexible fiber capable of performing three crucial neurological functions simultaneously: recording neural activity, delivering therapeutic drugs, and stimulating multiple brain regions.

The UK’s Advanced Research and Invention Agency (Aria) has allocated £54 million to fund 14 biotechnology projects designed to accelerate the adaptation of British wildlife to the climate crisis. These initiatives aim to leverage biological solutions to help species cope…

The U.S. Food and Drug Administration (FDA) granted accelerated approval on Thursday to rebisufligene etisparvovec, marketed as Fayuvi, marking the first gene therapy authorized for pediatric patients diagnosed with mucopolysaccharidosis type IIIA (MPS IIIA), commonly known as Sanfilippo syndrome type…

Researchers successfully integrated human brain organoids into the brains of mice, a significant advancement published online on September 16, 2026, in the journal Nature. This groundbreaking xenocortication technique allows for the analysis of human neurodevelopment at both the circuit…

Leaders of major artificial intelligence companies have recently voiced significant concerns regarding the potential dangers posed by the technology they are developing. Dario Amodei, CEO of Anthropic, stated last weekend that AI carries serious risks and advocated for slowing down…